Category Archives: Pharmaceutical - Part 2

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(6)

Over 300 submissions for listing (200 with economic evaluations) have been considered by the PBAC since the first edition was published. After consultation with industry, the second edition of the Guidelines was published in November 1995. The major focus of … Continue reading

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(5)

The listing process If a company wishes to have a product included on the PBS, it must apply for listing with the Pharmaceutical Benefits Branch of the Department of Health and Family Services. The application must include an economic evaluation. … Continue reading

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(4)

The federal government has other provisions for reimbursing drug costs for a small number of specific programs, including an emergency drug (doctor’s) bag supplies program, vaccination programs, stoma appliances (through Stoma Associations, Canberra, Australia) and diabetic supplies (through Diabetes Australia, … Continue reading

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(3)

Patients who would like a brand of drug that costs more than the lowest price subsidized by the scheme are required to pay the difference between the lowest priced brand and the brand prescribed. A minimum pricing policy was introduced … Continue reading

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(2)

The major aim of the restriction system is to try to direct use of a drug to the population in which it is most likely to be cost effective. An ‘authority listing’ means that approval must be sought from the … Continue reading

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(1)

PBS The PBS is a national, universal, prescription drug insurance scheme, administered by the Commonwealth government. It is the buyer for the country and operates as a monopsony (ie, sole purchaser). It was established in 1953 to provide access to … Continue reading

The Australian national publicly subsidized: LICENSING(2)

This translates into approximately 230 calender days. In 1994/95, 856 prescription drugs were processed for inclusion in the Australian Register of Therapeutic Goods (33 for new chemical entities). When approved, the drug is entered on the Australian Register of Therapeutic … Continue reading

The Australian national publicly subsidized: LICENSING(1)

The Therapeutic Goods Administration (TGA), a division of the Commonwealth Department of Health, is responsible for licensing a drug for marketing. It is similar to the Canadian Health Protection Branch, Health Canada. It operates under the Therapeutic Goods Act and, … Continue reading

The Australian national publicly subsidized Pharmaceutical Benefits Scheme: Any lessons for Canada?(2)

The Australian Pharmaceutical Benefits Scheme (PBS) is interesting for Canadians to examine because of the largely public-funded health system and its federation government. Australia, with a population of 19 million, has a bicameral parliamentary system and is a federation of … Continue reading

The Australian national publicly subsidized Pharmaceutical Benefits Scheme: Any lessons for Canada?(1)

Federal and provincial governments in Canada have initiated reforms in health care in a search for effectiveness and efficiency. Pharmaceuticals have been one of the areas targeted for reform. The cost of pharmaceuticals (including prescription drugs) as a percentage of … Continue reading

Pages: Prev 1 2